Angina. Ischaemic heart diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Receiving Nitroglycerin infusion for the first time Receiving Acetaminophen PRN Not having a history of sublingual Nitroglycerin use Not having a history of migraine or chronic headaches No sensitivity to Acetaminophen No sensitivity to medicinal Plants Lack of olfactory disorders Ability to swallow Ability to speak
Exclusion criteria
Exclusion criteria: Hypotension Drug susceptibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain scale by VAS scale. Timepoint: The evaluation of the patient's headache at 5, 10, 15, and 60 minutes after the onset of Nitroglycerine infusion. Method of measurement: The evaluation of the patient's headache in three groups (Acetaminophen, Lavender essential oil and control) at 5, 10, 15, and 60 minutes after the onset of Nitroglycerine infusion will be measured.;Comfort scale by VAS scale. Timepoint: The evaluation of the patient's comfort 15 minutes before infusion and at 60 minutes after initiation of nitroglycerin infusion. Method of measurement: The evaluation of the patient's comfort (VAS) 15 minutes before infusion and at 60 minutes after initiation of nitroglycerin infusion in three groups (acetaminophen, lavender essential oil and control) will be measured. | — |
Countries
Iran (Islamic Republic of)
Contacts
Hamedan University of Medical Sciences